Rules 4.7.3 and 4.10.3 ASX Listing Rules Appendix 4G (current at 17/7/2020) Page 1 Appendix 4G Key to Disclosures Corporate Governance Council Principles and Recommendations Name of entity MEMPHASYS LIMITED ABN/ARBN Financial year ended: 33 120 047 556 30 JUNE 2026 Our...
Appendix 4G and Corporate Governance Statement
Filed with ASX ·
6ix hasn’t read this filing yet.
Earlier from Memphasys
- Appendix 4E and 2026 Annual Report
- Felix Early Thai FDA Approval, Commercial Launch Accelerates
- Results of General Meeting
- Felix Registration Achieved in Vietnam and Cartridge Order
- Pivotal Felix Study Receives First Scientific Presentation
Later from Memphasys
- EUR526,500 Nordic Agreement Expands Felix European Footprint
- Notification of cessation of securities - MEM
- Felix Registration Achieved in Turkey, Sales Commence
- Investor Webinar Invite
- Memphasys Investor Webinar Presentation - September 2026
Follow Memphasys into a list and get an email when it puts out news.
Follow Memphasys